CVS HEALTH P Market Value
| 126650CL2 | 99.63 0.06 0.06% |
| Symbol | 126650CL2 |
126650CL2 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to 126650CL2's bond what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of 126650CL2.
| 01/02/2025 |
| 02/01/2025 |
If you would invest 0.00 in 126650CL2 on January 2, 2025 and sell it all today you would earn a total of 0.00 from holding CVS HEALTH P or generate 0.0% return on investment in 126650CL2 over 30 days. 126650CL2 is related to or competes with Emerson Radio, Allient, GameStop Corp, Amkor Technology, Kulicke, Arrow Electronics, and Analog Devices. More
126650CL2 Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure 126650CL2's bond current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CVS HEALTH P upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.34) | |||
| Maximum Drawdown | 2.04 | |||
| Value At Risk | (0.57) | |||
| Potential Upside | 0.3014 |
126650CL2 Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for 126650CL2's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as 126650CL2's standard deviation. In reality, there are many statistical measures that can use 126650CL2 historical prices to predict the future 126650CL2's volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.03) | |||
| Total Risk Alpha | (0.07) | |||
| Treynor Ratio | 0.6433 |
CVS HEALTH P Backtested Returns
CVS HEALTH P secures Sharpe Ratio (or Efficiency) of -0.076, which signifies that the bond had a -0.076 % return per unit of risk over the last 3 months. CVS HEALTH P exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm 126650CL2's Standard Deviation of 0.3665, mean deviation of 0.2224, and Risk Adjusted Performance of (0.07) to double-check the risk estimate we provide. The bond shows a Beta (market volatility) of -0.0516, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning 126650CL2 are expected to decrease at a much lower rate. During the bear market, 126650CL2 is likely to outperform the market.
Auto-correlation | -0.62 |
Very good reverse predictability
CVS HEALTH P has very good reverse predictability. Overlapping area represents the amount of predictability between 126650CL2 time series from 2nd of January 2025 to 17th of January 2025 and 17th of January 2025 to 1st of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CVS HEALTH P price movement. The serial correlation of -0.62 indicates that roughly 62.0% of current 126650CL2 price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.62 | |
| Spearman Rank Test | -0.75 | |
| Residual Average | 0.0 | |
| Price Variance | 0.19 |
CVS HEALTH P lagged returns against current returns
Autocorrelation, which is 126650CL2 bond's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting 126650CL2's bond expected returns. We can calculate the autocorrelation of 126650CL2 returns to help us make a trade decision. For example, suppose you find that 126650CL2 has exhibited high autocorrelation historically, and you observe that the bond is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
126650CL2 regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If 126650CL2 bond is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if 126650CL2 bond is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in 126650CL2 bond over time.
Current vs Lagged Prices |
| Timeline |
126650CL2 Lagged Returns
When evaluating 126650CL2's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of 126650CL2 bond have on its future price. 126650CL2 autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, 126650CL2 autocorrelation shows the relationship between 126650CL2 bond current value and its past values and can show if there is a momentum factor associated with investing in CVS HEALTH P.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in 126650CL2 Bond
126650CL2 financial ratios help investors to determine whether 126650CL2 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 126650CL2 with respect to the benefits of owning 126650CL2 security.